johnson johnson

News Digest for 2 november 2022

⚠️ U.S. Release. The Fed interest rate decision will take place today at 21:00 (Mosk. time) ⚠️ Today will be held U.S. Federal Open Market Committee (FOMC) Press Conference in 21:30 (Mosk. time) Analyst Expect, that the Fed and the Bank of England at meetings on Wednesday and Thursday, respectively, will raise the stakes on 75 b.p.. (* to 3.75-4.00% in the U.S. and up to 3.00% in the UK) Expected, that the Fed will raise rates today 0.75% and give a signal, which can slow down the rate of increase. ? Bitcoin – $20 473 (↑0,40%) ? S&P 500 – 3 859 (↓0,33%) ?? USD/RUB – 61,97 (↑1,59%) ?? USD/UAH – 36,88 (↑0,00%) ? Gold – $1 652 (↑0,74%) ⚫️ Oil Brent – $94,66 (↑2,30%)

Market news: bankruptcy Johnson & Johnson and Mountain Reporting

Johnson & Johnson is going to declare bankruptcy, to resolve the issue of possible claims. Lordstown Motors will get a ton of money in exchange for nothing and set an example for other scams.. And let's also look at the reports of companies, which were previously reviewed on the site.

Investor Calendar: Airbnb, eBay and DoorDash To Release Reports

Every day of the company, that are traded on the stock market, disclose information about the business: publish financial statements, hold press conferences, present new products and approve dividends. We have collected all the important events of the coming week for those, who invests in securities.

Johnson & Johnson reported revenue and profit growth and raised its forecast for the year

The largest company in the healthcare sector Johnson & Johnson (NYSE: JNJ) published a report for the second quarter of 2021: revenue increased by 27,1%, up to $23.3 billion; operating sales excluding exchange rates increased by 23%; net profit increased by 73,1%, up to 6.3 billion; net margin increased from 19.8 to 26,9%; adjusted net income increased by 49%, up to 6.6 billion; adjusted net margin increased from 24.2 to 28,4%. By regions The company divides sales by two regions: U.S. and other countries. USA (U. S.) — 51%. Revenue increased by 24,9%, up to 11.9 billion. Other countries (International) — 49%. Revenue increased by 29,5%, up to 11.4 billion. Of them 20,9% — operating sales, 8,6% - the influence of the exchange rate. By segment The company has three operating segments: consumer goods, pharmaceuticals and medical devices. Consumer goods (Consumer Health) — 16%. Revenue increased by 13,3%, up to 3.7 billion. Consumer Healthcare Market Continues to Recover After COVID-19 Negative Impact. Increased sales of skin care products, cosmetics and over-the-counter drugs. Pharmaceutics (Pharmaceutical) — 54%. Revenue increased by 17,2%, up to 12.6 billion. Sales of drugs for the treatment of psoriasis increased, myeloma and cancer. Medical devices (Medical Devices) — 30%. Revenue increased by 62,7%, up to 7 billion. Sales in this segment grew the most. A year ago, in the midst of a pandemic, Medical centers refurbished to deal with coronavirus. Non-urgent operations postponed, so the demand for equipment fell. Now, when the number of new cases of COVID-19 infections decreased, medical facilities are returning to their daily operations. Прогноз Компания повысила свои ожидания по росту выручки и скорректированной чистой прибыли на акцию в 2021 году. Revenue: It was: 9,7—10,9%, up to 90.6-91.6 billion; Became: 10,5—11,5%, up to 91.3-92.1 billion; including vaccine: 13,5—14,5%, up to 93.8-94.6 billion. Adjusted net earnings per share: …

Johnson & Johnson reported revenue and profit growth and raised its forecast for the year Read more

Johnson & Johnson will pay 230 billion dollars in opioid cases

26 June Pharmaceutical Company Johnson & Johnson (NYSE: JNJ) announced the conclusion of a settlement agreement with the state of New York in the opioid case. For 9 years the company will pay the state 230-260 million dollars as compensation. More J&J will not be able to promote opioid drugs as locally, as well as at the national level.

Financial reporting calendar : Western Union, UnitedHealth and QIWI will pay securities income

What is financial reporting? When you buy shares, you acquire a share in the business. Roughly speaking: If everything is fine in business, the value of the shares rises. If everything is bad, the price drops. Therefore, it is useful for the financier to look, how is the company doing. The most common way to do this is to read the money statement.. From it one can understand, how much the company has helped, earned, spent and borrowed. The report also allows you to calculate the potential income from securities., and the very fact of the publication of the report affects the mood of financiers and the value of shares. How to read the reports of public companies How to evaluate the price of companies What reports to look at for a financier 1 neighborhood 2021 of the year.

Scroll to Top